# Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia

> **NCT06400940** · PHASE4 · RECRUITING · sponsor: **Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health** · enrollment: 640 (estimated)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DRUG:** ticagrelor (tablets, 180 mg) or prasugrel (tablets, 10 mg).
- **DRUG:** combination of clopidogrel (tablets, 75 mg) and acetylsalicylic acid (ASA, tablets, 100 mg) or a combination of ticagrelor (tablets, 180 mg) and ASA (tablets, 100 mg).

## Key facts

- **NCT ID:** NCT06400940
- **Lead sponsor:** Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-17
- **Primary completion:** 2026-08-17
- **Final completion:** 2028-08
- **Target enrollment:** 640 (ESTIMATED)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400940, "Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06400940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*